Information
Address

Gustave Roussy
114, rue Édouard-Vaillant
94805 Villejuif Cedex - France
Switchboard:

Switchboard

+33 (0)1 42 11 42 11

GUSTAVE ROUSSY
1st cancer center in Europe

© 2006-2015 Gustave Roussy – All rights reserved

UMR 9019

back to job offer list
back to clinical trials

UMR 9019 - Genome Integrity and Cancers

The Genome Integrity and Cancers unit focuses its efforts on understanding the molecular and cellular mechanisms that govern the stability of the genome, one of the major areas of research at the Gustave Roussy Institute.

Etude ONCOVID

back to job offer list
back to clinical trials

Etude ONCOVID

Covid-19 - Epidémiologie du SARS-CoV-2 et mortalité par maladie de Covid-19 chez les patients français porteurs d’un cancer et traités par l'hydroxychloroquine et l'azithromycine.

Programme de rechercher COVID-19
04/22/2020

Covid-19 : un programme de recherche d’envergure à Gustave Roussy

Fort de ressources en recherche biomédicale uniques en Europe, Gustave Roussy a lancé dès la fin mars 2020 un programme de recherche d’envergure sur le Covid-19 et plus particulièrement sur ses interactions avec le cancer

COVID-19 News

back to job offer list
back to clinical trials

Synthèse d'actualités scientifiques liées au COVID-19, réalisée par des experts de Gustave Roussy.

COVID-19 News | 23 mars 2020

back to job offer list
back to clinical trials

Synthèse d'actualités scientifiques liées au COVID-19, réalisée par des experts de Gustave Roussy.

COVID-19 News | 20 mars 2020

back to job offer list
back to clinical trials

Synthèse d'actualités scientifiques liées au COVID-19, réalisée et commentée par des experts de Gustave Roussy.

Genomics of Non-Melanoma Skin Cancer - Team

back to job offer list
back to clinical trials

Computational biology and biology of non melanoma skin cancers
Lab members

  • Dr Andrey Yurchenko (Post-Doctoral Fellow, GR )
  • Dr. Ismael Padioleau (Engineer, GR)
  • Dr. Fatemeh Rajabi (PostDoctoral Fellow, GR)
  • Mr Denis Vorobyev (Engineer)
  • Mr Pierre Laplante (PhD student)

 

Computational biology and biology of non melanoma skin cancers - Publications

back to job offer list
back to clinical trials

Computational biology and biology of non melanoma skin cancers - Major publications

    Computational biology and biology of non melanoma skin cancers

    back to job offer list
    back to clinical trials

    Computational biology and biology of non melanoma skin cancers

    The team is supported by ARC foundation grant: "Emerging Leaders in Oncology".

    This team belongs to the UMR 981:"Molecular predictors and new targets in oncology".

    03/20/2019

    Precision drug to stimulate immune system against some cancers

    Gustave Roussy's researchers found an unkown ability to PARP inihibitors - a precision cancer drug used against breast and ovarian cancer - to stimulate the immune system. This study suggests to developp new combinaisons of treatments with immunotherapy.

    Pages